SEI INVESTMENTS CO - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 124 filers reported holding INSYS THERAPEUTICS INC NEW in Q2 2016. The put-call ratio across all filers is 5.78 and the average weighting 0.1%.

Quarter-by-quarter ownership
SEI INVESTMENTS CO ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2017$0
-100.0%
6
-100.0%
0.00%
-100.0%
Q1 2016$1,294,000
-42.7%
80,924
+2.5%
0.01%
-42.9%
Q4 2015$2,260,000
+7.2%
78,945
+6.6%
0.01%
-26.3%
Q3 2015$2,109,000
+26.1%
74,091
+59.1%
0.02%
+26.7%
Q2 2015$1,673,000
+11.8%
46,573
+80.8%
0.02%
+15.4%
Q1 2015$1,497,000
+46.0%
25,758
+5.9%
0.01%
+44.4%
Q4 2014$1,025,00024,3140.01%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q2 2016
NameSharesValueWeighting ↓
Orbimed Advisors 3,028,354$30,526,0000.37%
Engineers Gate Manager LP 96,105$969,0000.07%
BOOTHBAY FUND MANAGEMENT, LLC 61,600$621,0000.06%
GAM Holding AG 83,940$846,0000.03%
SHELL ASSET MANAGEMENT CO 90,282$910,0000.02%
SFMG, LLC 11,994$107,0000.02%
QS Investors, LLC 159,133$1,604,0000.02%
Winslow, Evans & Crocker, Inc. 4,060$42,0000.01%
PANAGORA ASSET MANAGEMENT INC 285,646$2,879,0000.01%
PEAK6 Investments LLC 225,800$2,276,0000.01%
View complete list of INSYS THERAPEUTICS INC NEW shareholders